Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms

Virology

Volumn 259, Issue 2, 1999, Pages 384-391

  Suzuki, Takeshi ^a   Narita, Tomoko ^a   Uchida Toita, Masami ^a   Yoshida, Mitsuaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; TAX PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL TRANSFORMATION; DOWN REGULATION; ENZYME REACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0033526810     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9760     Document Type: Article

References (42)

1. Akagi T., Ono H., Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene. 12:1996;1645-1652.
2. Alcorta D. A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J. C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93:1996;13742-13747.
3. Blais A., Labrie Y., Pouliot F., Lachance Y., Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochem. Biophys. Res. Commun. 247:1998;146-153.
4. Brauweiler A., Garrus J. E., Reed J. C., Nyborg J. K. Repression of bax gene expression by the HTLV-1 Tax protein: Implications for suppression of apoptosis in virally infected cells. Virology. 231:1997;135-140.
5. Chan F. K., Zhang J., Cheng L., Shapiro D. N., Winoto A. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol. Cell Biol. 15:1995;2682-2688.
6. Drexler H. G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845-859.
7. Erickson S., Sangfelt O., Heyman M., Castro J., Einhorn S., Grander D. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene. 17:1998;595-602.
8. Franklin D. S., Godfrey V. L., Lee H., Kovalev G. I., Schoonhoven R., Chen-Kiang S., Su L., Xiong Y. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:1998;2899-2911.
9. Grana X., Reddy E. P. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 11:1995;211-219.
10. Guan K. L., Jenkins C. W., Li Y., Nichols M. A., Wu X., O'Keefe C. L., Matera A. G., Xiong Y. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:1994;2939-2952.
11. Hannon G. J., Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 371:1994;257-261.
12. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell Biol. 16:1996;859-867.
13. Herman J. G., Jen J., Merlo A., Baylin S. B. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56:1996;722-727.
14. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA. 78:1981;6476-6480.
15. Hirai H., Roussel M. F., Kato J. Y., Ashmun R. A., Sherr C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15:1995;2672-2681.
16. Hollsberg P., Ausubel L. J., Hafler D. A. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. J. Immunol. 153:1994;566-573.
17. Hunter T., Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
18. Inoue J., Seiki M., Taniguchi T., Tsuru S., Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 5:1986;2883-2888.
19. Jeang K. T., Widen S. G., Semmes O. J. T., Wilson S. H. HTLV-1 trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science. 247:1990;1082-1084.
20. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S. R., Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
21. Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47:1994;157-166.
22. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
23. Lemasson I., Robert-Hebmann V., Hamaia S., Duc Dodon M., Gazzolo L., Devaux C. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax. J. Virol. 71:1997;1975-1983.
24. Low K. G., Dorner L. F., Fernando D. B., Grossman J., Jeang K. T., Comb M. J. Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J. Virol. 71:1997;1956-1962.
25. Malumbres M., Perez de Castro I., Santos J., Melendez B., Mangues R., Serrano M., Pellicer A., Fernandez-Piqueras J. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Oncogene. 14:1997;1361-1370.
26. Matsushime H., Quelle D. E., Shurtleff S. A., Shibuya M., Sherr C. J., Kato J.-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14:1994;2066-2076.
27. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA. 93:1996;1320-1324.
28. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
29. Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:1994;753-756.
30. Phelps D. E., Hsiao K. M., Li Y., Hu N., Franklin D. S., Westphal E., Lee E. Y., Xiong Y. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell Biol. 18:1998;2334-2343.
31. Pines J. Cyclins and cyclin-dependent kinases: Take your partners. Trends Biochem. Sci. 18:1993;195-197.
32. Poeisz B. J., Ruscetti R. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of the C retrovirus from fresh and cultured lymphocytes of a patient with T cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
33. Reynisdottir I., Polyak K., Iavarone A., Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1995;1831-1845.
34. Serrano M., Hannon G. J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707.
35. Serrano M., Lin A. W., McCurrach M. E., Beach D., Lowe S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
36. Sherr C. J. G1 progression: Cycling on cue. Cell. 79:1994;1059-1065.
37. Suzuki T., Kitao S., Matsushime H., Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15:1996;1607-1614.
38. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
39. Uittenbogaard M. N., Armstrong A. P., Chiaramello A., Nyborg J. K. Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J. Biol Chem. 269:1994;22466-22469.
40. Yoshida M. HTLV-1 Tax: Regulation of gene expression and disease. Trends Microbiol. 1:1993;131-135.
41. Yoshida M. HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms. J. Cancer Res. Clin. Oncol. 121:1995;521-528.
42. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 79:1982;2031-2035.